Contact Us
Genomic Cancer Panel And Profiling Global Market Report 2025
Global Genomic Cancer Panel And Profiling Market Report 2025
Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF
Purchase This Report

Genomic Cancer Panel And Profiling Global Market Report 2025

By Tissue Testing (Solid Tissue Testing, Liquid Tissue Testing), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Other Technologies), By Cancer Panel Type (Single-Gene Panel, Multi-Gene Panel), By Application (Clinical, Research), By End User (Hospitals, Research And Academic Institutes, Clinical And Diagnostic Laboratories, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Genomic Cancer Panel And Profiling Market Overview

• Genomic Cancer Panel And Profiling market size has reached to $9.47 billion in 2024

• Expected to grow to $14.27 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%

• Growth Driver: Rising Cancer Incidence Driving The Growth Of The Market Due To Aging Population And Improved Detection

• Market Trend: Enhancing Diagnostic Accuracy Through Technological Integration

North America was the largest region in 2024.

What Is Covered Under Genomic Cancer Panel And Profiling Market?

Genomic cancer panel and profiling is a molecular diagnostic technique that analyzes multiple genes simultaneously to detect genetic mutations, alterations, or biomarkers associated with cancer. Its primary purpose is to guide personalized treatment decisions, predict disease progression, and improve cancer diagnosis and monitoring.

The main tissue testing types in the genomic cancer panel and profiling market are solid tissue testing and liquid tissue testing. Solid tissue testing is a diagnostic procedure that analyzes samples from solid tumors or organs to identify genetic mutations, biomarkers, or disease characteristics. Various technologies are used in this process, such as next-generation sequencing (NGS), polymerase chain reaction (PCR), fluorescence in-situ hybridization (FISH), immunohistochemistry (IHC), and others, with cancer panels including single-gene panels and multi-gene panels. These tests are used in a variety of applications, including clinical and research settings, by end users such as hospitals, research and academic institutes, clinical and diagnostic laboratories, and other end users.

Genomic Cancer Panel And Profiling Market Size and growth rate 2025 to 2029: Graph

What Is The Genomic Cancer Panel And Profiling Market Size 2025 And Growth Rate?

The genomic cancer panel and profiling market size has grown strongly in recent years. It will grow from $9.47 billion in 2024 to $10.28 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rising global cancer burden, rising use in clinical trials, expansion of diagnostic infrastructure, growing awareness of genetic testing, and increasing government and research funding.

What Is The Genomic Cancer Panel And Profiling Market Growth Forecast?

The genomic cancer panel and profiling market size is expected to see strong growth in the next few years. It will grow to $14.27 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to the expansion of liquid biopsy applications, growing use in early detection, expansion of liquid biopsy applications, growth in tailored therapies, and increasing companion diagnostics approvals. Major trends in the forecast period include integration of AI and machine learning in genomic data interpretation, development of multi-omics approaches, cloud-based genomic data storage and analysis, integration with electronic health records, and expansion of next-generation sequencing (NGS) platforms.

The forecast of 8.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. cancer centers by driving up the cost of multi-gene panel tests and tumor sequencing platforms imported from the UK and Singapore, delaying targeted therapy decisions and increasing precision oncology costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Genomic Cancer Panel And Profiling Market Segmented?

1) By Tissue Testing: Solid Tissue Testing, Liquid Tissue Testing

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Other Technologies

3) By Cancer Panel Type: Single-Gene Panel, Multi-Gene Panel

4) By Application: Clinical, Research

5) By End User: Hospitals, Research And Academic Institutes, Clinical And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Solid Tissue Testing: Biopsy Samples, Surgical Resection Samples, Formalin-Fixed Paraffin-Embedded (FFPE) Tissues, Fresh Frozen Tissues

2) By Liquid Tissue Testing: Blood, Urine, Saliva, Cerebrospinal Fluid (CSF), Other Bodily Fluids

What Is Driving The Genomic Cancer Panel And Profiling Market? Rising Cancer Incidence Driving The Growth Of The Market Due To Aging Population And Improved Detection

Rising cancer incidence is expected to propel the growth of the genomic cancer panel and profiling market going forward. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells in the body. Increasing cancer incidence can be attributed to factors such as an aging population, which leads to a higher risk of developing cancer as people live longer. Genomic cancer panels and profiling are used in cancer to identify genetic mutations and biomarkers, enabling personalized treatment plans and improving early detection and monitoring of the disease. For instance, in January 2024, according to the American Cancer Society, a U.S.-based nonprofit organization, in 2022, around 20 million new cancer cases were reported globally, resulting in 9.7 million deaths; driven primarily by population growth, the global cancer burden is projected to rise to 35 million cases by 2050. Therefore, rising cancer incidence will drive the growth of the genomic cancer panel and profiling industry.

Who Are The Major Players In The Global Genomic Cancer Panel And Profiling Market?

Major companies operating in the genomic cancer panel and profiling market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., Predictive Oncology Inc.

What Are The Key Trends Of The Global Genomic Cancer Panel And Profiling Market? Enhancing Diagnostic Accuracy Through Technological Integration

Major companies operating in the genomic cancer panel and profiling market are focusing on technological advancements such as next-generation sequencers to improve the accuracy, speed, and comprehensiveness of cancer diagnostics and enable more personalized treatment decisions. Next-generation sequencers are advanced DNA sequencing technologies that enable rapid, high-throughput analysis of genetic material to identify mutations, variations, and other genomic features. For instance, in April 2025, QIAGEN N.V., a Netherlands-based biotechnology company, launched QIAseq panels designed for next-generation sequencers, enabling comprehensive genomic profiling by analyzing over 700 genes. These panels are intended for both research and clinical applications, aiming to improve cancer diagnostics and treatment strategies.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Genomic Cancer Panel And Profiling Market? Quest Diagnostics Strengthens Cancer Testing With Haystack Oncology Acquisition

In June 2023, Quest Diagnostics, a US-based clinical laboratory company, acquired Haystack Oncology for an undisclosed amount. Through its acquisition, Quest Diagnostics expanded its capabilities in liquid biopsy and cancer detection, enhancing its genomic testing offerings. Haystack Oncology is a US-based biotech company focused on developing innovative liquid biopsy technologies for early cancer detection and monitoring.

What Is The Regional Outlook For The Global Genomic Cancer Panel And Profiling Market?

North America was the largest region in the genomic cancer panel and profiling market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Genomic Cancer Panel And Profiling Market?

The genomic cancer panel and profiling market consists of revenues earned by entities by providing services such as genetic mutation analysis, companion diagnostic testing, cancer risk assessment, and screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The genomic cancer panel and profiling market also includes sales of targeted gene panels, companion diagnostic kits, sequencing platforms and instruments, bioinformatics software, and analysis tools. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Genomic Cancer Panel And Profiling Industry?

The genomic cancer panel and profiling market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the genomic cancer panel and profiling industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Genomic Cancer Panel And Profiling Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $10.28 billion
Revenue Forecast In 2034 $14.27 billion
Growth Rate CAGR of 8.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The genomic cancer panel and profiling market covered in this report is segmented –
1) By Tissue Testing: Solid Tissue Testing, Liquid Tissue Testing
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Other Technologies
3) By Cancer Panel Type: Single-Gene Panel, Multi-Gene Panel
4) By Application: Clinical, Research
5) By End User: Hospitals, Research And Academic Institutes, Clinical And Diagnostic Laboratories, Other End Users Subsegments:
1) By Solid Tissue Testing: Biopsy Samples, Surgical Resection Samples, Formalin-Fixed Paraffin-Embedded (FFPE) Tissues, Fresh Frozen Tissues
2) By Liquid Tissue Testing: Blood, Urine, Saliva, Cerebrospinal Fluid (CSF), Other Bodily Fluids
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., Predictive Oncology Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Genomic Cancer Panel And Profiling Market Characteristics

3. Genomic Cancer Panel And Profiling Market Trends And Strategies

4. Genomic Cancer Panel And Profiling Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Genomic Cancer Panel And Profiling Growth Analysis And Strategic Analysis Framework

5.1. Global Genomic Cancer Panel And Profiling PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Genomic Cancer Panel And Profiling Market Growth Rate Analysis

5.4. Global Genomic Cancer Panel And Profiling Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Genomic Cancer Panel And Profiling Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Genomic Cancer Panel And Profiling Total Addressable Market (TAM)

6. Genomic Cancer Panel And Profiling Market Segmentation

6.1. Global Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Solid Tissue Testing

Liquid Tissue Testing

6.2. Global Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Next-Generation Sequencing (NGS)

Polymerase Chain Reaction (PCR)

Fluorescence In-Situ Hybridization (FISH)

Immunohistochemistry (IHC)

Other Technologies

6.3. Global Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Single-Gene Panel

Multi-Gene Panel

6.4. Global Genomic Cancer Panel And Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinical

Research

6.5. Global Genomic Cancer Panel And Profiling Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Research And Academic Institutes

Clinical And Diagnostic Laboratories

Other End Users

6.6. Global Genomic Cancer Panel And Profiling Market, Sub-Segmentation Of Solid Tissue Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biopsy Samples

Surgical Resection Samples

Formalin-Fixed Paraffin-Embedded (FFPE) Tissues

Fresh Frozen Tissues

6.7. Global Genomic Cancer Panel And Profiling Market, Sub-Segmentation Of Liquid Tissue Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Blood

Urine

Saliva

Cerebrospinal Fluid (CSF)

Other Bodily Fluids

7. Genomic Cancer Panel And Profiling Market Regional And Country Analysis

7.1. Global Genomic Cancer Panel And Profiling Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Genomic Cancer Panel And Profiling Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genomic Cancer Panel And Profiling Market

8.1. Asia-Pacific Genomic Cancer Panel And Profiling Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genomic Cancer Panel And Profiling Market

9.1. China Genomic Cancer Panel And Profiling Market Overview

9.2. China Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genomic Cancer Panel And Profiling Market

10.1. India Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genomic Cancer Panel And Profiling Market

11.1. Japan Genomic Cancer Panel And Profiling Market Overview

11.2. Japan Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genomic Cancer Panel And Profiling Market

12.1. Australia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genomic Cancer Panel And Profiling Market

13.1. Indonesia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genomic Cancer Panel And Profiling Market

14.1. South Korea Genomic Cancer Panel And Profiling Market Overview

14.2. South Korea Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genomic Cancer Panel And Profiling Market

15.1. Western Europe Genomic Cancer Panel And Profiling Market Overview

15.2. Western Europe Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genomic Cancer Panel And Profiling Market

16.1. UK Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genomic Cancer Panel And Profiling Market

17.1. Germany Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genomic Cancer Panel And Profiling Market

18.1. France Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genomic Cancer Panel And Profiling Market

19.1. Italy Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genomic Cancer Panel And Profiling Market

20.1. Spain Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genomic Cancer Panel And Profiling Market

21.1. Eastern Europe Genomic Cancer Panel And Profiling Market Overview

21.2. Eastern Europe Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genomic Cancer Panel And Profiling Market

22.1. Russia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genomic Cancer Panel And Profiling Market

23.1. North America Genomic Cancer Panel And Profiling Market Overview

23.2. North America Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genomic Cancer Panel And Profiling Market

24.1. USA Genomic Cancer Panel And Profiling Market Overview

24.2. USA Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genomic Cancer Panel And Profiling Market

25.1. Canada Genomic Cancer Panel And Profiling Market Overview

25.2. Canada Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genomic Cancer Panel And Profiling Market

26.1. South America Genomic Cancer Panel And Profiling Market Overview

26.2. South America Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genomic Cancer Panel And Profiling Market

27.1. Brazil Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genomic Cancer Panel And Profiling Market

28.1. Middle East Genomic Cancer Panel And Profiling Market Overview

28.2. Middle East Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genomic Cancer Panel And Profiling Market

29.1. Africa Genomic Cancer Panel And Profiling Market Overview

29.2. Africa Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genomic Cancer Panel And Profiling Market Competitive Landscape And Company Profiles

30.1. Genomic Cancer Panel And Profiling Market Competitive Landscape

30.2. Genomic Cancer Panel And Profiling Market Company Profiles

30.2.1. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Genomic Cancer Panel And Profiling Market Other Major And Innovative Companies

31.1. Sysmex Corporation

31.2. QIAGEN N.V.

31.3. Exact Sciences Corporation

31.4. ARUP Laboratories

31.5. Tempus Labs

31.6. Genscript Biotech Corporation

31.7. NeoGenomics Inc.

31.8. Foundation Medicine

31.9. Invitae Corporation

31.10. Guardant Health Inc.

31.11. Caris Life Sciences

31.12. Fulgent Genetics

31.13. NanoString Technologies Inc.

31.14. Genecast Biotechnology Co. Ltd

31.15. Burning Rock DX

32. Global Genomic Cancer Panel And Profiling Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genomic Cancer Panel And Profiling Market

34. Recent Developments In The Genomic Cancer Panel And Profiling Market

35. Genomic Cancer Panel And Profiling Market High Potential Countries, Segments and Strategies

35.1 Genomic Cancer Panel And Profiling Market In 2029 - Countries Offering Most New Opportunities

35.2 Genomic Cancer Panel And Profiling Market In 2029 - Segments Offering Most New Opportunities

35.3 Genomic Cancer Panel And Profiling Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Genomic Cancer Panel And Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Genomic Cancer Panel And Profiling Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Genomic Cancer Panel And Profiling Market, Sub-Segmentation Of Solid Tissue Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Genomic Cancer Panel And Profiling Market, Sub-Segmentation Of Liquid Tissue Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Genomic Cancer Panel And Profiling Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Genomic Cancer Panel And Profiling Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Hoffmann-La Roche Ltd Financial Performance
  • Table 79: Thermo Fisher Scientific Inc. Financial Performance
  • Table 80: Agilent Technologies Inc. Financial Performance
  • Table 81: Hologic Inc. Financial Performance
  • Table 82: Illumina Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Genomic Cancer Panel And Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Genomic Cancer Panel And Profiling Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Genomic Cancer Panel And Profiling Market, Sub-Segmentation Of Solid Tissue Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Genomic Cancer Panel And Profiling Market, Sub-Segmentation Of Liquid Tissue Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Genomic Cancer Panel And Profiling Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Genomic Cancer Panel And Profiling Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Hoffmann-La Roche Ltd Financial Performance
  • Figure 79: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 80: Agilent Technologies Inc. Financial Performance
  • Figure 81: Hologic Inc. Financial Performance
  • Figure 82: Illumina Inc. Financial Performance

Frequently Asked Questions

Genomic cancer panel and profiling is a molecular diagnostic technique that analyzes multiple genes simultaneously to detect genetic mutations, alterations, or biomarkers associated with cancer. Its primary purpose is to guide personalized treatment decisions, predict disease progression, and improve cancer diagnosis and monitoring. For further insights on this market, request a sample here

The market major growth driver - Rising Cancer Incidence Driving The Growth Of The Market Due To Aging Population And Improved Detection. For further insights on this market, request a sample here

The genomic cancer panel and profiling market size has grown strongly in recent years. It will grow from $9.47 billion in 2024 to $10.28 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rising global cancer burden, rising use in clinical trials, expansion of diagnostic infrastructure, growing awareness of genetic testing, and increasing government and research funding. The genomic cancer panel and profiling market size is expected to see strong growth in the next few years. It will grow to " $14.27 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to the expansion of liquid biopsy applications, growing use in early detection, expansion of liquid biopsy applications, growth in tailored therapies, and increasing companion diagnostics approvals. Major trends in the forecast period include integration of AI and machine learning in genomic data interpretation, development of multi-omics approaches, cloud-based genomic data storage and analysis, integration with electronic health records, and expansion of next-generation sequencing (NGS) platforms. For further insights on this market, request a sample here

The genomic cancer panel and profiling market covered in this report is segmented –
1) By Tissue Testing: Solid Tissue Testing, Liquid Tissue Testing
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Other Technologies
3) By Cancer Panel Type: Single-Gene Panel, Multi-Gene Panel
4) By Application: Clinical, Research
5) By End User: Hospitals, Research And Academic Institutes, Clinical And Diagnostic Laboratories, Other End Users Subsegments:
1) By Solid Tissue Testing: Biopsy Samples, Surgical Resection Samples, Formalin-Fixed Paraffin-Embedded (FFPE) Tissues, Fresh Frozen Tissues
2) By Liquid Tissue Testing: Blood, Urine, Saliva, Cerebrospinal Fluid (CSF), Other Bodily Fluids For further insights on this market,
request a sample here

North America was the largest region in the genomic cancer panel and profiling market in 2024. The regions covered in the genomic cancer panel and profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the genomic cancer panel and profiling market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., Predictive Oncology Inc. . For further insights on this market, request a sample here.

Major trends in this market include Enhancing Diagnostic Accuracy Through Technological Integration. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon